• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用瑞士奶酪模型“切片”脑胶质母细胞瘤的驱动基因。

'Slicing' glioblastoma drivers with the Swiss cheese model.

机构信息

Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA; Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Case Comprehensive Cancer Center, Cleveland, OH 44195, USA; Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Trends Cancer. 2024 Jan;10(1):15-27. doi: 10.1016/j.trecan.2023.08.002. Epub 2023 Aug 23.

DOI:10.1016/j.trecan.2023.08.002
PMID:37625928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10840711/
Abstract

The Swiss cheese model is used to assess risks and explain accidents in a variety of industries. This model can be applied to dissect the homeostatic mechanisms whose cumulative dysregulation contributes to disease states, including cancer. Using glioblastoma (GBM) as an exemplar, we discuss how specific protumorigenic mechanisms collectively drive disease by affecting genomic integrity, epigenetic regulation, metabolic homeostasis, and antitumor immunity. We further highlight how host factors, such as hormonal differences and aging, impact this process, and the interplay between these 'system failures' that enable tumor progression and foster therapeutic resistance. Finally, we examine therapies that consider the interactions between these elements, which may comprise more effective approaches given the multifaceted protumorigenic mechanisms that drive GBM.

摘要

瑞士奶酪模型用于评估各种行业的风险和解释事故。该模型可用于剖析稳态机制,其累积失调导致疾病状态,包括癌症。我们以胶质母细胞瘤 (GBM) 为例,讨论了特定的促瘤机制如何通过影响基因组完整性、表观遗传调控、代谢稳态和抗肿瘤免疫来共同驱动疾病。我们还进一步强调了宿主因素(如激素差异和衰老)如何影响这一过程,以及这些“系统故障”之间的相互作用,这些相互作用使肿瘤进展并促进治疗耐药性。最后,我们研究了考虑这些因素相互作用的治疗方法,鉴于驱动 GBM 的多方面促瘤机制,这些方法可能构成更有效的方法。

相似文献

1
'Slicing' glioblastoma drivers with the Swiss cheese model.用瑞士奶酪模型“切片”脑胶质母细胞瘤的驱动基因。
Trends Cancer. 2024 Jan;10(1):15-27. doi: 10.1016/j.trecan.2023.08.002. Epub 2023 Aug 23.
2
Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma.炎症的表观遗传学基础:揭示胶质母细胞瘤肿瘤微环境的关键。
Front Immunol. 2022 Apr 29;13:869307. doi: 10.3389/fimmu.2022.869307. eCollection 2022.
3
Epigenetic pathways and glioblastoma treatment: insights from signaling cascades.表观遗传途径与胶质母细胞瘤治疗:来自信号级联反应的见解
J Cell Biochem. 2015 Mar;116(3):351-63. doi: 10.1002/jcb.24990.
4
Nanoparticle-based drug delivery systems to modulate tumor immune response for glioblastoma treatment.基于纳米颗粒的药物递送系统,用于调节肿瘤免疫反应以治疗胶质母细胞瘤。
Acta Biomater. 2025 Mar 1;194:38-57. doi: 10.1016/j.actbio.2025.01.050. Epub 2025 Jan 29.
5
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma.表观遗传修饰对胶质母细胞瘤适应性耐药进化的影响。
Int J Mol Sci. 2021 Aug 3;22(15):8324. doi: 10.3390/ijms22158324.
6
Histone acetyltransferases as promising therapeutic targets in glioblastoma resistance.组蛋白乙酰转移酶作为胶质母细胞瘤耐药治疗的有希望的靶点。
Cancer Lett. 2024 Nov 1;604:217269. doi: 10.1016/j.canlet.2024.217269. Epub 2024 Sep 24.
7
Epigenetic pathways and glioblastoma treatment.表观遗传途径与胶质母细胞瘤治疗。
Epigenetics. 2013 Aug;8(8):785-95. doi: 10.4161/epi.25440. Epub 2013 Jun 27.
8
Epigenetic Mechanisms Histone Deacetylase-Dependent Regulate the Glioblastoma Angiogenic Matrisome and Disrupt Endothelial Cell Behavior In Vitro.表观遗传机制组蛋白去乙酰化酶依赖性调控胶质母细胞瘤血管生成的基质并破坏体外内皮细胞行为。
Mol Cell Proteomics. 2024 Mar;23(3):100722. doi: 10.1016/j.mcpro.2024.100722. Epub 2024 Jan 23.
9
Tumor Cell Invasion in Glioblastoma.脑胶质瘤中的肿瘤细胞侵袭。
Int J Mol Sci. 2020 Mar 12;21(6):1932. doi: 10.3390/ijms21061932.
10
Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.长链非编码 RNA HOTAIRM1 通过上调 HOXA1 并将 G9a/EZH2/Dnmts 从 HOXA1 基因上隔离,从而促进胶质母细胞瘤中肿瘤的生长和侵袭。
J Exp Clin Cancer Res. 2018 Oct 30;37(1):265. doi: 10.1186/s13046-018-0941-x.

引用本文的文献

1
A novel role of exostosin glycosyltransferase 2 (EXT2) in glioblastoma cell metabolism, radiosensitivity and ferroptosis.外生骨疣糖基转移酶2(EXT2)在胶质母细胞瘤细胞代谢、放射敏感性和铁死亡中的新作用。
Cell Death Differ. 2025 Apr 15. doi: 10.1038/s41418-025-01503-w.
2
Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment.缺氧诱导的补体成分 3 促进脑胶质母细胞瘤微环境中的侵袭性肿瘤生长。
JCI Insight. 2024 Aug 22;9(19):e179854. doi: 10.1172/jci.insight.179854.
3
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.

本文引用的文献

1
Cancer Cells Promote Immune Regulatory Function of Macrophages by Upregulating Scavenger Receptor MARCO Expression.癌细胞通过上调清道夫受体 MARCO 的表达促进巨噬细胞的免疫调节功能。
J Immunol. 2023 Jul 1;211(1):57-70. doi: 10.4049/jimmunol.2300029.
2
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.溶瘤病毒 DNX-2401 联合派姆单抗治疗复发性胶质母细胞瘤:一项 1/2 期试验。
Nat Med. 2023 Jun;29(6):1370-1378. doi: 10.1038/s41591-023-02347-y. Epub 2023 May 15.
3
The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
了解胶质瘤的免疫抑制微环境:机制见解和临床观点。
J Hematol Oncol. 2024 May 8;17(1):31. doi: 10.1186/s13045-024-01544-7.
4
Roles of extracellular vesicles in glioblastoma: foes, friends and informers.细胞外囊泡在胶质母细胞瘤中的作用:敌人、朋友与情报员
Front Oncol. 2023 Nov 24;13:1291177. doi: 10.3389/fonc.2023.1291177. eCollection 2023.
缺氧和癌症干细胞在胶质母细胞瘤发展中的作用
Cancers (Basel). 2023 May 4;15(9):2613. doi: 10.3390/cancers15092613.
4
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity.GAP43 依赖性线粒体从星形胶质细胞转移增强了神经胶质瘤的致瘤性。
Nat Cancer. 2023 May;4(5):648-664. doi: 10.1038/s43018-023-00556-5. Epub 2023 May 11.
5
Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma.单核细胞耗竭增强胶质母细胞瘤中中性粒细胞的浸润和神经前体细胞向间质转化。
Nat Commun. 2023 Apr 3;14(1):1839. doi: 10.1038/s41467-023-37361-8.
6
Integrative analysis of single-cell transcriptomics reveals age-associated immune landscape of glioblastoma.单细胞转录组学的综合分析揭示胶质母细胞瘤与年龄相关的免疫景观。
Front Immunol. 2023 Jan 24;14:1028775. doi: 10.3389/fimmu.2023.1028775. eCollection 2023.
7
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.胶质母细胞瘤的免疫检查点阻断:从肿瘤异质性到个体化治疗。
J Clin Invest. 2023 Jan 17;133(2):e163447. doi: 10.1172/JCI163447.
8
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-B /IL-6/STAT3 and JNK/PTX3 pathways.鞘氨醇激酶1通过增强由NF-κB/IL-6/STAT3和JNK/PTX3信号通路介导的炎症反应来促进胶质母细胞瘤的生长。
Acta Pharm Sin B. 2022 Dec;12(12):4390-4406. doi: 10.1016/j.apsb.2022.09.012. Epub 2022 Sep 29.
9
Active DNA demethylation promotes cell fate specification and the DNA damage response.活性 DNA 去甲基化促进细胞命运特化和 DNA 损伤反应。
Science. 2022 Dec 2;378(6623):983-989. doi: 10.1126/science.add9838. Epub 2022 Dec 1.
10
The emerging field of oncolytic virus-based cancer immunotherapy.溶瘤病毒为基础的癌症免疫疗法的新兴领域。
Trends Cancer. 2023 Feb;9(2):122-139. doi: 10.1016/j.trecan.2022.10.003. Epub 2022 Nov 17.